Growth failure in cystic fibrosis: a true need for anabolic agents?
Colombo
Carla
C
Battezzati
Alberto
A
D045930:Anabolic Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications*; D004041:Dietary Fats / Q000008:administration & dosage; D002149:Energy Intake; D004734:Energy Metabolism; D006130:Growth Disorders / Q000150:complications*; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D044342:Malnutrition / Q000150:complications*; D009751:Nutritional Requirements; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
D045930:Anabolic Agents; D004041:Dietary Fats; D011994:Recombinant Proteins; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I